Deferred Tax Assets, Valuation Allowance of scPharmaceuticals Inc. from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
scPharmaceuticals Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • scPharmaceuticals Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $94,093,000, a 29% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

scPharmaceuticals Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $94,093,000 +$20,936,000 +29% 31 Dec 2024 10-K 19 Mar 2025 2024 FY
Q4 2023 $73,157,000 +$14,071,000 +24% 31 Dec 2023 10-K 19 Mar 2025 2024 FY
Q4 2022 $59,086,000 +$7,687,000 +15% 31 Dec 2022 10-K 19 Mar 2025 2024 FY
Q4 2021 $51,399,000 +$8,320,000 +19% 31 Dec 2021 10-K 13 Mar 2024 2023 FY
Q4 2020 $43,079,000 +$9,081,000 +27% 31 Dec 2020 10-K 22 Mar 2022 2021 FY
Q4 2019 $33,998,000 +$9,291,000 +38% 31 Dec 2019 10-K 23 Mar 2021 2020 FY
Q4 2018 $24,707,000 +$8,055,000 +48% 31 Dec 2018 10-K 24 Mar 2020 2019 FY
Q4 2017 $16,652,000 31 Dec 2017 10-K 21 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.